E/M Coding Alert - 2003 Issue 7
PRESCRIPTION DRUGS: Family Practitioners, Oncologists Hit by Drug Cuts
Subscribe or sign in to view the full article.
Article Overview
This article reviews a Medicare reimbursement update affecting multiple prescription and injectable drugs used by family practitioners, oncologists, and other clinicians. It explains the general scope of the payment reductions, identifies the affected drug categories, and notes why the changes matter for billing and reimbursement planning.
Why This Topic Matters
Readers who bill or code for injectable drugs need to know which Medicare-covered drugs were subject to payment reductions so they can assess financial impact and monitor carrier reimbursement updates.
What You Will Learn
- What types of prescription drug reimbursement changes were announced
- Which broad clinical areas were affected by the payment cuts
- Why Medicare drug payment updates matter for reimbursement workflows
- How policy updates can affect office economics for injectable drug billing
Who Should Read This
- Family practitioners
- Oncologists
- Infectious disease clinicians
- Medical coders
- Billing staff
- Practice managers
- Reimbursement specialists
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com